2016
504 Optimal Timing for Hepatitis C Treatment in Cirrhotic Patients Awaiting Liver Transplantation: A Cost-Effectiveness Analysis
Njei B, McCarty T, Ditah I, Lim J, Fortune B. 504 Optimal Timing for Hepatitis C Treatment in Cirrhotic Patients Awaiting Liver Transplantation: A Cost-Effectiveness Analysis. Gastroenterology 2016, 150: s1037. DOI: 10.1016/s0016-5085(16)33505-3.Peer-Reviewed Original Research
2012
Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication
Bruce RD, Eiserman J, Acosta A, Gote C, Lim JK, Altice FL. Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication. The American Journal Of Drug And Alcohol Abuse 2012, 38: 206-212. PMID: 22242700, PMCID: PMC5573865, DOI: 10.3109/00952990.2011.643975.Peer-Reviewed Original ResearchConceptsSustained virologic responseEarly virologic responseMethadone maintenance treatmentHepatitis C treatmentSelf-administered therapyHepatitis C virusHCV treatmentVirologic responseAdherence supportWeek 12HCV treatment adherenceOpioid-dependent patientsBlood-borne infectionsMethadone-maintained patientsCompletion of treatmentCase-control studyMethadone maintenance clinicsMethadone maintenance programMental illness comorbidityConcurrent substance useC treatmentObserved therapyHCV genotypesHIV statusIllness comorbidity
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply